# The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria

> **NCT00346606** · PHASE4 · UNKNOWN · sponsor: **Lotus Pharmaceutical** · enrollment: 60 (—)

## Conditions studied

- Chronic Idiopathic Urticaria
- Urticaria

## Interventions

- **DRUG:** Denosin® and Xyzal®

## Key facts

- **NCT ID:** NCT00346606
- **Lead sponsor:** Lotus Pharmaceutical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 60 (—)
- **Last updated:** 2006-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00346606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00346606, "The Efficacy and Safety of Desloratadine With Levocetirizine in Treatment of Chronic Idiopathic Urticaria". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00346606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*